Clinical Trials · NCT00296465
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Three Dosage Strengths of Pulsatile GnRH
- Phase
- Phase 2/Phase 3
- Recruitment status
- Completed
- Sponsor
- Ferring Pharmaceuticals
- Enrollment
- 132
- Start date
- Feb 2005
- Locations
- 1 site, United States
- Primary endpoint
- Pregnancy rate